Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody

• 收藏
• 分享

专利权人:

Janssen Biotech; Inc.

发明人:

Matteo Cesaroni,Matthew Loza,Jarrat Jordan,Loqmane Seridi

申请号：

US16415231

公开号：

US20190352388A1

申请日:

2019.05.17

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Methods for selecting and treating patients with active Systemic Lupus Erythematosus (SLE) that are predicted to have an increased likelihood of having a positive response to a treatment with a safe and effective amount of an anti-IL-12/IL-23p40 antibody or an anti-IL-23 antibody, e.g., informs on what patients to treat with the anti-IL-12/IL-23p40 antibody ustekinumab.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/